Brought to you by 
ChromaVision gets $5mm in private placement from Safeguard
23 Feb 2004
Executive Summary
Cellular imaging company ChromaVision Medical Systems raised $5mm through the private placement of stock to life sciences incubator Safeguard Scientifics, its largest shareholder. The company sold 2.3mm common shares at $2.18 each, a 21% discount to the market average.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Cytology
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ChromaVision gets $5mm in private placement from Safeguard
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice